Will Radionetics receive FDA approval for a new radiopharmaceutical by mid-2025? | Binary | | | 6 months ago | |
Will Lilly announce another strategic agreement with a biotech company by end of 2024? | Binary | | | 6 months ago | |
Will Lilly acquire Radionetics Oncology by end of 2024? | Binary | | | 6 months ago | |
How much revenue will Radionetics generate from the Lilly deal by end of 2025? | Categorical | | | 6 months ago | |
Will Eli Lilly's 2024 EPS exceed revised guidance? | Binary | | | 2 months ago | |
Which clinical trial phase will Radionetics' leading radiopharmaceutical reach by end of 2025? | Categorical | | | 6 months ago | |
What will be Eli Lilly's adjusted EPS for Q4 2024? | Categorical | | | 2 months ago | |
Will Mounjaro sales reach $3.62 billion in Q4 2024? | Binary | | | 2 months ago | |
Will Eli Lilly shares recover to pre-Q3 2024 levels by end of 2024? | Binary | | | 2 months ago | |
What will be Eli Lilly's revenue growth rate for 2024? | Categorical | | | 2 months ago | |
Will Eli Lilly exercise an option for additional collaboration with Insitro by 2025? | Binary | | | 3 months ago | |
Will Insitro achieve a milestone payment from Eli Lilly collaboration by 2025? | Binary | | | 3 months ago | |
Will Insitro's first drug from Eli Lilly collaboration enter clinical trials by 2026? | Binary | | | 3 months ago | |
Which regulatory authority will first approve a drug from Insitro-Eli Lilly collaboration by 2028? | Categorical | | | 3 months ago | |
Which will be Eli Lilly's top-selling drug in Q4 2024? | Categorical | | | 2 months ago | |
What will be the first therapeutic area targeted by Insitro's drug from Eli Lilly collaboration by 2026? | Categorical | | | 3 months ago | |
What will be the primary AI technology in Insitro's drug development from Eli Lilly collaboration by 2025? | Categorical | | | 3 months ago | |
What major milestone will Radionetics achieve by end of 2024? | Categorical | | | 6 months ago | |
